ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
RevImmune Advances New COVID-19 Immunotherapy americanpharmaceuticalreview
November 04, 2020RevImmune announced its "ILIAD-7" international randomized controlled Phase 2 trial in patients critically ill with COVID-19, is now enrolling patients at five sites in the U.S.
Pharma Sources Insight July 2025
